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Variability in phase and amplitude 
of diurnal rhythms is related to 
variation of mood in bipolar and 
borderline personality disorder
O. Carr  1, K. E. A. Saunders2,3, A. Tsanas4,5, A. C. Bilderbeck2, N. Palmius  1, J. R. Geddes2,3, 
R. Foster6, G. M. Goodwin2,3,6 & M. De Vos1,6
Variable mood is an important feature of psychiatric disorders. However, its measurement and 
relationship to objective measureas of physiology and behaviour have rarely been studied. Smart-
phones facilitate continuous personalized prospective monitoring of subjective experience and 
behavioural and physiological signals can be measured through wearable devices. Such passive data 
streams allow novel estimates of diurnal variability. Phase and amplitude of diurnal rhythms were 
quantified using new techniques that fitted sinusoids to heart rate (HR) and acceleration signals. We 
investigated mood and diurnal variation for four days in 20 outpatients with bipolar disorder (BD), 
14 with borderline personality disorder (BPD) and 20 healthy controls (HC) using a smart-phone app, 
portable electrocardiogram (ECG), and actigraphy. Variability in negative affect, positive affect, and 
irritability was elevated in patient groups compared with HC. The study demonstrated convincing 
associations between variability in subjective mood and objective variability in diurnal physiology. For 
BPD there was a pattern of positive correlations between mood variability and variation in activity, 
sleep and HR. The findings suggest BPD is linked more than currently believed with a disorder of diurnal 
rhythm; in both BPD and BD reducing the variability of sleep phase may be a way to reduce variability of 
subjective mood.
Bipolar disorder (BD) is associated with periods of elated and depressed mood interspersed by periods of relative 
stability or euthymia. Major mood episodes can last for weeks to months1,2. However, even when well, people 
with BD experience considerable inter-episode mood instability. Such instability is not unique to BD. It is also 
reported as a major problem by patients with borderline personality disorder (BPD) and is present in a surprising 
14% of the general population in whom it appears to be a risk factor for a variety of negative psychiatric outcomes, 
including suicide3.
Mood instability is not well understood. One way to imagine its origin is to start from mechanisms that confer 
stability on biological systems. The best characterised example is perhaps the circadian or clock system present 
in all cells and particularly highly organized for regulation of brain function. Disruption of sleep is observed to 
be a prominent feature of psychiatric disorders in general and BD in particular4,5, which will operate through the 
homeostat, and the possible intrinsic variability in the diurnal rhythm of the clock. The effects of the clock are 
obvious in relation to jet lag, before the clock resets to local time after long haul travel. More subtle disruption of 
the clock’s diurnal rhythm has been studied infrequently in psychiatric patients. Thus, descriptions of sleep dis-
turbance tend to be informal and do not distinguish between homeostat and clock mechanisms in its causation.
Mood instability in BD disorder has been widely shown. Increased mood variability in euthymic BD patients 
compared to healthy controls has been shown through retrospective questionnaires, indicating BD is not 
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restricted to episodes of depression and mania but is also associated with mood instability between episodes6. 
More recent studies have used more continuous daily monitoring of mood in BD with smartphones, again finding 
increased mood variability in inter-episodic periods7,8. Patients with BPD are not as widely studied, however sim-
ilar affective lability has been described in BPD9. Daily self-reported mood collected using a novel smartphone 
app reveals increased mood variability in both BD and BPD10. In addition, mood variability measures were able to 
discriminate between the three subject groups, suggesting mood varies differently across the disorders.
Stabilization of diurnal rhythms in BD is the objective of a number of current treatments11. Initial studies on 
BD measured diurnal disturbance through alterations to the sleep-wake cycle using simple estimates of sleep 
onset and offset from diaries and questionnaires12. More recently, actigraphy and melatonin levels have been 
employed as more objective measures13–15. Longer term recordings of actigraphy allow a wider range of diurnal 
measures to be calculated, for example the least active 5 hours of nocturnal activity (L5), most active 10 hour 
period or average daily activity16. These measures, in addition to quantifying the phase of 24 hours of activity 
through fitting a sinusoid, found BD participants to have less regular diurnal rhythms compared to controls17,18. 
There have been far fewer studies on diurnal disruption in BPD but a relatively recent review by Fleischer et al. 
described evidence of altered diurnal rhythms in BPD, along with considerable sleep disturbance19. Preliminary 
candidate gene studies have also suggested a link between circadian genes and susceptibility to BD20.
Variability in diurnal rhythm or sleep may contribute to mood symptoms in BD and BPD. Variability in diur-
nal function can be quantified as activity in sleep-wake cycle variability21. Episodes of altered mood are associated 
with significant changes in activity levels, making measures of activity a potential marker for mood variability2. 
In addition, subtle changes in temperature and autonomic nervous system (ANS) function also vary in a diur-
nal cycle. Broadly speaking, sympathetic nervous system activity is activating (e.g. increasing heart rate (HR)), 
whereas parasympathetic nervous system activity imposes resting states in the body (e.g. returning the HR to a 
normal level)22. If diurnal instability is related to mood instability, objective measures of variability in activity, 
sleep and HR should correlate with variability of subjective experience1,17.
BD and BPD are important conditions with high morbidity and premature mortality (from suicide and cardi-
ovascular disease)23. Both are associated with variable mood, but BPD displays pervasive poor impulse control, 
instability of interpersonal relationship and disturbed self-image, with patients often expressing aggression in 
association with their emotional distress24. BPD and BD can be difficult to distinguish because of the overlapping 
features of mood instability and impulsivity, but mania is only seen in BD. BPD has been associated with disrup-
tions to the sleep-wake cycle and irregular behavioural patterns19, along with disruptions in the ANS25.
Diagnosis and monitoring of both BD and BPD has largely relied on retrospective self-reporting of symptoms, 
which is inherently unreliable and prone to recall bias26. We had previously demonstrated that mood variability 
differed significantly between BD, BPD, and healthy control (HC) participants, when monitored over a longitu-
dinal (multiple months) period10,27. Here, daily assessment of mood symptoms has been made using a compact 
clinical scale called Mood Zoom (MZ) delivered via a bespoke smart-phone app28. The responses to the MZ 
questionnaire have been shown to be highly correlated with the results of traditional questionnaires (QIDS29, 
GAD-730, and EQ-5D) for mood, anxiety and quality of life10.
The aims of this study were to: (a) develop a method of quantifying diurnal rhythm regularity, (b) explore how 
diurnal variability of activity, sleep, HR and variability in mood are altered in BD, BPD and HC (c) investigate the 
links between diurnal variability and mood variability in BD and BPD participants.
Data
The data was collected as part of the Automated Monitoring of Symptom Severity (AMoSS) study at the University 
of Oxford28. Participants gave written informed consent for a protocol approved by the NRES Committee East of 
England - Norfolk (13/EE/0288), all methods were carried out in accordance with the Code of Ethics of the World 
Medical Association (Declarations of Helsinki of 1975) for experiments involving humans. The AMoSS study col-
lected behavioural data from participants31, in addition to self-reported mood scores using a smartphone app, as 
well as self-reported clinically validated questionnaires to determine psychiatric state10,27. Participants diagnosed 
with BD or BPD and healthy controls were recruited for the study through previous studies, local advertising and 
word-of-mouth. All the participants were screened by an experienced psychiatrist (KEAS) using the Structured 
Clinical Interview for DSM IV. They agreed initially for a three month period of recording, with the option of con-
tinuing participating in the study and providing mood recordings beyond the first three months. Data collection 
started in March 2014 and the data analysed here was collected up until February 2016, with 54 BD, 34 BPD and 
53 HC participants recruited.
For one week during the study, the participants underwent ‘high intensity’ monitoring, during which multiple 
signals were recorded from a Proteus patch (www.proteus.com), stuck to the torso of participants. The patch was 
not removed during the whole ‘high intensity’ week and recorded HR and acceleration in three directions at one 
sample per minute.
Mood data was collected through the MZ smart-phone application, which prompted participants to provide 
their mood ten times evenly spaced throughout each day. The prompts typically started at 10am and finished at 
8pm, thus on average mood characteristics were self-reported every hour. Participants rated six mood items in 
the smart-phone application: anxious, elated, sad, angry, irritable and energetic on a seven point Likert scale from 
zero, corresponding to ‘not at all’, to six, corresponding to ‘very much’. For further details on MZ see Tsanas et al.10.
The HR data obtained from the Proteus patch gave an average over five minute intervals; it did not permit 
measurement of conventional beat-to-beat heart rate variability. However, the data allowed for long term analysis 
of diurnal patterns in physiological and behavioural measures. The acceleration signals are recorded in vertical, 
horizontal and forward directions, with a sampling frequency of 0.017 Hz (once per minute). The reliability of the 
patches was variable so recordings from individual participant ranged from complete failure to eight days. Only 
participants who had four or more days of recording were included to allow a good representation of diurnal 
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variability; the first four days of the recording were selected in order to standardise the analysis across all partic-
ipants. The first day of ‘high intensity’ monitoring varied and we have not discriminated between weekdays and 
weekends.
Disposal of participants is shown in Table 1. Recordings were attempted on 113 participants (43 BD, 26 BPD 
and 44 HC) and satisfactory data analysed from 20 BD participants, 14 BPD participants and 20 HC. Of the 113 
participants where recordings were attempted, 22 were discarded due to the devices failing to record any data, 
with the other 37 discarded as the recordings were shorter than four days.
BD and BPD participants were taking a range of different medications (Table 1); BD: anticonvulsants, antipsy-
chotics, lithium and antidepressants; BPD: mainly antidepressants. All correlations described below ignored med-
ication. This is because there were no obvious differences in the pattern between variability of mood, variability of 
diurnal measures or correlations with and without medication when statistical tests were applied.
Methods
Mood Zoom Data. Principal component analysis was previously applied to the MZ questionnaire, with the 
first three components used to quantify the negative, positive and irritable moods of participants10. Variability of 
MZ scores were quantified using the standard deviation, the mean of the Teager-Kaiser energy operator (TKEO), 
entropy, and root mean squared successive differences (RMSSD) of each mood score. The MZ variability meas-
ures are defined as:
std
N
x1 ( )
(1)i
N
i x
1
2∑ μ= −
=
TKEO
N
x x x1 ( )
(2)i
N
i i i
2
1
2
1 1∑= −
=
−
− +
entropy p x p x( )log( ( ))
(3)i
N
i i
1
∑=
=
∑= −
=
−
+RMSSD N
x x1 ( )
(4)i
N
i i
1
1
1
2
where N is the total number of samples in the signal (number of MZ entries), xi is the ith value of the signal (ith MZ 
entry) and μx is the mean of the signal (mean MZ entry).
The variability measures were calculated on the principal components of MZ for the four days corresponding 
to the HR and actigraphy recordings. The approximate sampling frequency is one entry per hour, however there 
will be a nightly gap for each 24 hour period where no MZ entries are recorded.
Bipolar Disorder
Borderline Personality 
Disorder Healthy Controls
Originally Recruited
Participants 54 34 53
High Intensity Recordings
Participants 43 26 44
Processed Data
Participants 20 14 20
Gender 6 male; 14 female 2 male; 12 female 4 male; 16 female
Age (mean ± std) 41.0 ± 11.4 34.3 ± 10.2 43.4 ± 14.6
BMI (mean ± std) 26.1 ± 3.9 25.9 ± 5.1 24.6 ± 4.2
QIDS (mean ± std) 7.78 ± 5.50 12.35 ± 4.70 2.04 ± 1.53
Altman (mean ± std) 1.06 ± 1.21 2.69 ± 3.17 0.15 ± 0.67
Any psychotropic medication 18 10 0
Lithium 7 0 0
Anticonvulsant 11 1 0
Antipsychotic 11 3 0
Antidepressant 7 10 0
Hypnotics 1 0 0
Anxiolyticz 1 3 0
Table 1. Numbers of participants recruited for the study and who had high intensity week recordings. 
Information for the participants who had data processed for analysis.
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Extracting Diurnal Rhythms. HR data was pre-processed to remove artefacts in the signal. The value of 
HR at each recorded instance was compared to the value recorded at the preceding time instance: if the value was 
over 150% or under 50% of the previous value the value at the current time was set to the mean of the preceding 
and succeeding values. Artefacts were typically only one sample long and imputing values based on an average 
over a larger period had no impact on results, therefore it was decided to use the simple approach of averaging 
previous and succeeding values. A mean of 1% ± 1.2% of the data was adjusted due to artefacts for each partici-
pant. An indicative example of the recorded data is presented in Fig. 1. The HR signals exhibited a natural sinu-
soidal behaviour (Fig. 1e). The acceleration signals did not show this pattern as clearly, therefore the signals were 
integrated to emphasise this sinusoidal behaviour (see Fig. 1b and d). The integration was performed by centring 
the signals on zero by subtracting the means, and then integrating an overlapping window of six hours which is 
shifted by one data point along the entire signal.
Quantification of diurnal rhythms allowed for the analysis of behavioural and physiological regularity within 
participants or subject groups. A number of previous studies on diurnal rhythms of HR have performed fitting 
of a sine wave to a 24 hour signal by quantifying the phase, average value and amplitude, known as the Cosinor 
method32–34. Here, this analysis has been extended to longer term signals over a number of days through fitting 
of sine waves to both the entire signal and to each 24 hour section of the signal for integrated total acceleration, 
integrated vertical acceleration and HR (see Fig. 1b,d and e).
The diurnal analysis was performed on the HR signal, in addition to the integrated total acceleration signal (a 
measure of total activity) and the integrated vertical acceleration signal (a measure of sleep or rest-activity, due to 
changing reference angle of the wearer). We fitted directly to the raw HR signal from midday to midday in order 
to emphasise the night time behaviour, as shown in red. The sinusoids were fit with a fixed period of 24 hours and 
the amplitude and phase were optimised to give a least squares fit. Secondly, a sinusoidal fit was carried out on the 
entire signal to provide an average diurnal pattern for the length of the signal, with an identical fitting method as 
the daily fits, shown in black. The same technique of fitting sinusoids was applied to the integrated total accelera-
tion signal, to give a diurnal measure of activity and also to the integrated vertical acceleration; this gave a diurnal 
measure of lying down, used as a proxy for measuring sleep or rest-activity levels.
Diurnal Parameters. Diurnal features were calculated by comparing the daily sinusoid fits of HR, total 
acceleration and vertical acceleration to the total sinusoid fits to the same data. The similarity between the daily 
and total fits indicates the degree of diurnal regularity during the period of measurement.
Differences between the fits were measured through differences in the midline estimating statistic of rhythm 
(MESOR) (Fig. 1f, ①), or average, the phase (Fig. 1f, ②) and the amplitude (the difference between a and b) 
(Fig. 1f, ③); the timings of the minimum values of the daily sinusoidal fits are found (Td), as well as the ampli-
tudes (Ad) and MESORs (Md), in addition to the timings of the minimum values for the total (or weekly) sinu-
soidal fit (Tw) and the corresponding amplitudes (Aw) and MESORs (Mw). Details of the calculations are given 
as Supplementary Material.
Figure 1. An example of data recorded for the Proteus patch for one participant. (a) total acceleration, (b) the 
integrated total acceleration, (c) vertical acceleration, and (d) the integrated vertical acceleration. (e) the HR 
with a sinusoid fit to each 24 hour period in red and to the total data in black. (f) the comparison between daily 
and total sinusoids with difference between midline estimating statistic of rhythms (MESORs) ①, phases ② and 
amplitudes ③ shown.
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These new measures quantify regularity of diurnal rhythms over longitudinal recordings. They encapsulate 
how the timings (phase) of the rhythms are shifting along with how both the average (MESOR) and range (ampli-
tude) of recordings differ from day to day, as well as giving an overall measure of diurnal regularity through the 
RMS error between the daily and total sinusoids. The standard measures reported in the literature are based on 
actigraphy measures defined almost two decades ago: these include most active and least active periods and 
transitions between rest and activity16. A Cosinor method has also been used which quantifies phase, amplitude 
and MESOR, and can be generalised to other recordings (such as heart rate34). However, the new measures which 
find the difference from an average or total Cosinor fit for each day allow for better measures of regularity on an 
individual participant level.
Statistical Tests. Our analysis plan tested the hypothesis that variability of diurnal rhythms would be asso-
ciated with variation in mood. We investigated differences between the groups through diurnal features extracted 
from HR, integrated total acceleration and integrated vertical acceleration using the Wilcoxon rank sum test. To 
compute the correlation coefficients between diurnal features and MZ features, outliers were removed by calcu-
lating the Cook distance of each point: if the Cook distance of a point was greater than three times the mean Cook 
distance the point was removed as an outlier. An average of 1.6 ± 0.4 participants were removed as outliers for 
the calculation of the correlation coefficient for each pair of mood and diurnal measures. After outliers had been 
removed, Pearson correlation coefficients along with corresponding statistical significance (p-values) for each 
pair of diurnal feature and MZ feature were calculated. Correction for multiple statistical hypothesis tests was 
performed using the positive false discovery rate (significance at the 5% level), as defined by Storey, 200235. The 
positive false discovery rate aims to reduce the number of type I errors (incorrectly rejecting the null hypothesis). 
Here, the false discovery rate correction was separately applied to the statistical tests for: comparison of mood 
variability, diurnal variability and correlations.
Data availability. The datasets analysed during the study are available from the corresponding author on 
reasonable request.
Results
Mood Zoom variability. There were very large differences in all measures of daily MZ variability in negative 
mood, with BPD participants more variable than BD, who were more variable than HC (almost all differences are 
statistically significant, Table 2). A similar pattern was observed for daily measures of irritability and, to a lesser 
degree, positive mood. All pairwise comparisons were found to be statistically significant, with the exception of 
comparisons of positive MZ variability between BD and HC participants. Principal component weightings are 
described in more detail in Tsanas et al.10.
Diurnal variability: Heart rate, activity and sleep. The patterns of diurnal variability of participant 
groups can be best appreciated in spider plots of the medians of the standardised diurnal features for activity, 
sleep, and HR (Fig. 2). Figure 2 shows standardised measures, obtained by subtracting the mean and dividing by 
the standard deviation of each feature for the groups combined. Standardisation was only performed to compare 
metrics visually in Fig. 2. On inspection variability of activity measures was increased in the BPD; BD and HC were 
not distinguishable. For sleep, variability was greater in BPD participants for phase and amplitude measures; BD 
was also variable, but intermediate between BPD and HC. For HR, BPD group showed an increase in the MESOR 
compared with HC; BD and HC were similar (Fig. 2a). No standardisation was performed for statistical analysis 
and the observed differences represent trends which did not survive correction for multiple comparison (Table 3).
BD 
(median ± iqr)
BPD 
(median ± iqr)
HC 
(median ± iqr)
BDvs BPD 
(FDR)
BDvs HC 
(FDR)
BPDvs HC 
(FDR)
MZnegstd 0.99 ± 0.85 1.71 ± 1.11 0.35 ± 0.47 1.57E-03 2.31E-02 1.79E-04
MZnegTKEO 0.79 ± 0.88 1.94 ± 4.86 0.12 ± 0.43 1.37E-02 4.78E-02 6.62E-04
MZnegRMSSD 1.07 ± 0.64 1.69 ± 1.46 0.42 ± 0.62 2.02E-03 2.23E-02 2.03E-04
MZposentropy −6.67 ± 122.65 6.67 ± 3.91 −118.28 ± 414.04 4.34E-03 7.64E-02 7.76E-04
MZposstd 0.91 ± 0.70 1.42 ± 0.56 0.62 ± 0.52 1.21E-03 6.13E-01 7.76E-04
MZposTKEO 0.39 ± 0.77 1.40 ± 1.04 0.23 ± 0.54 2.02E-03 9.25E-01 4.34E-03
MZposRMSSD 0.91 ± 0.52 1.38 ± 0.54 0.66 ± 0.64 1.87E-03 7.35E-01 1.87E-03
MZposentropy −9.71 ± 134.27 3.83 ± 8.86 −65.57 ± 143.14 2.18E-03 4.14E-01 1.49E-03
MZirrstd 0.56 ± 0.43 1.01 ± 0.49 0.33 ± 0.46 1.87E-03 2.39E-02 2.98E-04
MZirrTKEO 0.24 ± 0.31 0.81 ± 0.69 0.09 ± 0.34 1.25E-03 5.43E-02 4.78E-04
MZirrRMSSD 0.71 ± 0.44 1.15 ± 0.41 0.40 ± 0.59 2.02E-03 4.34E-02 6.62E-04
MZirrentropy −23.90 ± 92.84 −3.50 ± 13.93 −188.99 ± 547.87 2.64E-03 5.27E-02 7.76E-04
Table 2. Comparing variability of all MZ recordings during the high intensity week across the three groups, 
and statistical significance pairwise comparisons across the three groups (BD, BPD, HC) using the Wilcoxon 
statistical hypothesis test and false discovery rate. Statistically significant differences at the FDR = 0.05 level 
appear in bold. “MZneg” denotes the negative principal component of MZ, “MZpos” denotes the positive 
principal component of MZ, and “MZirr” the irritability principal component of MZ computed using the PCA 
loadings10.
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Correlations between variation in mood and variation in diurnal measures. Correlations were 
calculated between the seven diurnal HR features, the seven diurnal activity features and the five diurnal sleep 
features and the standard deviation of MZ components. Statistically significant positive correlations were found 
in 14 of these pairs (after correcting for false discovery rate), shown in Table 4.
For total acceleration, BD showed no consistent correlations with mood, and no trend even for small positive 
correlations. This contrasted with the BPD and HC groups where all mood dimensions were highly positively 
correlated with variation in the stdMESOR, a measure of variability of average daily activity levels. BPD showed 
equally strong effect for RMS, a measure of overall variability of activity levels, but not diffMESOR, a measure 
of variability of day to day variability in average activity levels. HC showed a strong effect for diffMESOR and 
trended positive for RMS.
For the sleep measure, negative mood variability was highly correlated with stdPhase, a measure of variability 
of sleep timings, in BPD. High positive correlations were found between variability of all moon dimensions and 
Figure 2. Standardised median diurnal feature values across the three subject groups, separated into activity 
(a), sleep (b) and HR (c) features. stdPhase, stdMESOR and stdAmplitude denote the standard deviation 
of the differences between the daily and total sinusoid fit. diffPhase, diffMESOR and diffAmplitude denote 
the standard deviation of successive differences in the daily sinusoid fits. RMS is the root mean square error 
between the daily and total sinusoid fits. Measures were standardised by subtracting the mean and dividing by 
the standard deviation of each feature for the groups combined. Standardisation was only performed to visually 
compare measures in this figure.
Diurnal Features
BD 
(median ± iqr)
BPD 
(median ± iqr)
HC 
(median ± iqr)
Total Acceleration
stdPhase 1.48 ± 0.05 2.18 ± 0.09 1.52 ± 0.04
stdMESOR 0.0007 ± 0.0005 0.0009 ± 0.0005 0.0008 ± 0.0005
stdAmplitude 0.0006 ± 0.0004 0.0009 ± 0.0007 0.0006 ± 0.0006
diffPhase 2.29 ± 0.08 3.15 ± 0.16 2.75 ± 0.08
diffMESOR 0.0010 ± 0.0006 0.0012 ± 0.0006 0.0010 ± 0.0008
diffAmplitude 0.0009 ± 0.0007 0.0018 ± 0.0014 0.0008 ± 0.0010
RMS 0.000001 ± 0.000001 0.000001 ± 0.000001 0.000001 ± 0.000001
‘Sleep’
stdPhase 0.93 ± 0.03 1.17 ± 0.05 0.67 ± 0.02
stdAmplitude 0.017 ± 0.016 0.019 ± 0.017 0.015 ± 0.010
diffPhase 1.298 ± 0.048 1.462 ± 0.104 1.057 ± 0.023
diffAmplitude 0.03 ± 0.02 0.03 ± 0.03 0.02 ± 0.02
RMS 0.001 ± 0.001 0.001 ± 0.001 0.001 ± 0.001
Heart Rate
stdPhase 1.715 ± 0.074 1.467 ± 0.080 1.681 ± 0.104
stdMESOR 1.768 ± 1.756 3.196 ± 1.837 2.036 ± 1.422
stdAmplitude 2.03 ± 1.94 2.80 ± 2.06 2.74 ± 1.33
diffPhase 2.69 ± 0.10 1.94 ± 0.09 2.24 ± 0.11
diffMESOR 2.86 ± 3.71 4.81 ± 4.66 2.25 ± 2.46
diffAmplitude 2.80 ± 2.16 4.60 ± 2.57 4.13 ± 2.07
RMS 11.24 ± 9.81 16.71 ± 15.64 12.64 ± 12.81
Table 3. Comparing variability of diurnal features of HR, activity and sleep across the three groups, and 
statistical significance pairwise comparisons across the three groups (BD, BPD, HC) using the Wilcoxon 
statistical hypothesis test. No statistically significant differences were found after FDR correction.
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variability of sleep phases in BPD and similarly in BD with slightly smaller correlations. These correlations were 
not seen in HC participants.
For the HR measure in BPD, variation in signal amplitude was strongly positively correlated with measures of 
emotion. Neither the BD or HC groups showed even trend positive effects.
The absolute correlation coefficients for the groups can be appreciated in Fig. 3. For example, Fig. 3i shows 
the correlation coefficients between each of the diurnal HR features and the standard deviation of irritable mood, 
with BPD participants having large correlation coefficients, thus having a larger radius. The HC show little corre-
lation, with a small radius close to zero at the centre and the BD participants have small absolute correlations, thus 
a small radius. Another example in Fig. 3f shows BD and BPD participants having larger correlations between 
sleep and irritable mood variability through a larger radius, whereas the HC show few correlations.
For BPD participants what is notable is the generally larger correlation coefficients compared to the other 
groups for most correlations, but especially in the case of irritability and HR. For BD participants, vertical accel-
eration (sleep) showed clearly greater correlations with MZ measures than the HC group (and comparable with 
BPD).
For HC participants, activity showed relatively large correlation coefficients with MZ measures comparable 
with BPD and greater than BD.
Discussion
This exploratory study demonstrated convincing associations between variability in subjective mood and vari-
ability in measures of diurnal physiology for BPD. The differences between patient groups and healthy controls 
are of considerable interest. The BPD group showed greater variation in both mood and in diurnal physiology, 
however measured. By contrast, BD showed intermediate variation in mood (less than BPD, more than HC) and 
increased variability only in diurnal measures of sleep (less than BPD, more than HC) and not total activity or 
HR. Direct associations between variation in subjective mood and objective measures of diurnal variability were 
also demonstrated. Mood dimensions in both BPD and BD appeared more sensitive to variation in the phase and 
depth of sleep than HC. In addition, BPD showed clear evidence of an association between variability of HR and 
variation in irritability, a key symptom of the disorder. Mood variability in BD did not show this relationship. This 
may suggest that BPD, but not BD, should be thought of as a disorder linked with disorder of diurnal rhythm, 
although both appear to be influenced by variation in sleep.
We had already observed the distinctive differences in the variability of subjective mood experienced by BPD, 
BD and HC groups10. BPD was associated with high daily and, particularly, within day variation in negative, 
Diurnal Features
BD BPD HC
Correlation Coefficient Correlation Coefficient Correlation Coefficient
MZneg MZpos MZirr MZneg MZpos MZirr MZneg MZpos MZirr
Total Acceleration
stdPhase −0.374 −0.178 −0.122 0.206 0.470 0.174 0.219 0.174 0.176
stdMESOR 0.298 0.151 0.120 0.676 0.812** 0.276 0.448 0.691* 0.481
stdAmplitude 0.226 −0.292 0.020 0.465 0.724* 0.074 −0.052 0.258 −0.190
diffPhase −0.365 −0.174 −0.065 0.105 0.417 −0.104 0.049 0.251 −0.069
diffMESOR 0.332 0.252 0.225 −0.119 0.185 0.222 0.635 0.731* 0.658
diffAmplitude −0.037 −0.120 −0.241 0.452 0.733* 0.029 0.004 0.046 −0.012
RMS 0.100 −0.363 −0.065 0.923*** 0.887** 0.583 0.350 0.535 0.464
‘Sleep’
stdPhase 0.384 0.473 0.474 0.703* 0.617 0.521 −0.134 0.282 −0.112
stdAmplitude 0.411 0.595 0.618 −0.071 −0.035 0.492 −0.433 −0.423 −0.462
diffPhase 0.422 0.424 0.529 0.683 0.487 0.498 0.017 0.139 0.07
diffAmplitude 0.245 0.308 0.297 −0.397 −0.277 −0.068 −0.351 −0.413 −0.326
RMS 0.309 0.567 0.555 0.655 0.599 0.525 −0.118 0.015 0.071
Heart Rate
stdPhase −0.265 0.112 −0.177 0.427 0.690 0.276 −0.211 −0.092 −0.094
stdMESOR −0.145 0.141 −0.430 0.190 0.177 0.579 −0.125 0.096 −0.235
stdAmplitude −0.253 0.471 −0.171 0.781** 0.740* 0.761** 0.066 −0.139 −0.026
diffPhase −0.265 0.051 −0.087 0.395 0.503 0.441 −0.244 −0.068 −0.153
diffMESOR −0.195 0.229 −0.465 0.143 0.163 0.706* 0.108 0.559 0.248
diffAmplitude −0.367 0.136 −0.407 0.848** 0.687* 0.576 −0.038 −0.006 −0.092
RMS −0.195 0.115 −0.180 0.301 0.228 0.561 −0.198 0.303 −0.165
Table 4. Correlation coefficients between diurnal features and MZ features for BD, BPD and HC participants. 
Pearson correlation coefficients, with statistically significant correlations appearing in bold. *Represents 
the FDR = 0.05 level, **The FDR = 0.01 level and ***The FDR <0.001 level. For diurnal features, stdPhase, 
stdMESOR and stdAmplitude denote standard deviation of the difference between daily and total sinusoids 
measures. diff indicates the feature is the standard deviation of successive differences.
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positive and irritable mood dimensions compared with HC. BD variability was intermediate between BPD and 
HC. Recording the mood items up to ten times per day strongly discriminated the BPD group and also confirmed 
the clinical impression that mood is both more variable and at a higher frequency in BPD patients. High intensity 
monitoring can reduce the sampling interval required to acquire mood data in the future. The variation in the 
phase, average levels and amplitude of diurnal rhythms in BPD is a new observation. BPD was associated with the 
highest levels of variability in almost all the physiological measures as a trend and met conventional levels of sig-
nificance for a number of individual measures versus BD and HC. In contrast BD was not generally more variable 
than HC on the measures of activity and HR; there were trend effects for sleep. However, overall, variation in the 
physiological measures was less than the observed subjective variability.
We have previously suggested that mood instability is an important feature of the phenotype of both BD and 
BPD10. Despite the apparently less discriminating difference in the variability of diurnal signals, there appeared 
to be an important correlation between them. These correlations were most striking for both the BPD group in 
relation to activity and HR measures (Table 4). The present study did not determine the direction of effect, so we 
cannot say that variation in diurnal cycles drives mood variability. However, in the case of BD, this is the direction 
of effect suggested by observation of mood change in response to more obvious sleep disruption lasting many 
days. It would support the emphasis on sleep regularity on a day to day basis enshrined in the social rhythm met-
ric36 and other behavioural approaches to mood stabilization in BD37. More detailed measures of mood could be 
an important read out of the impact of effective treatment.
In relation to BPD, the observation that mood measures, especially irritability, are related to measures of sleep, 
activity and HR variability appears to be new. Previous measures of sleep in BPD have emphasized poor sleep quality 
Figure 3. Absolute correlation coefficients between diurnal variability measures and standard deviation of MZ 
measures to show how correlations vary across subject groups. Each spider plot represents a pair of diurnal 
HR, acceleration or vertical acceleration with negative MZ, positive MZ or irritable MZ measures. stdPhase, 
stdMESOR and stdAmplitude denote the standard deviation of the differences between the daily and total 
sinusoid fit. diffPhase, diffMESOR and diffAmplitude denote the standard deviation of successive differences in 
the daily sinusoid fits. RMS is the root mean square error between the daily and total sinusoid fits.
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and in some studies delayed sleep timing, but not a direct effect of variability per se. Again sleep regularity may be as 
important an objective for psychosocial interventions for BPD as for BD. This is not reflected in current practice38.
Variability in sleep was derived from the vertical component of the accelerometer worn on the chests of the 
participants. It is important that this signal was not the same as total acceleration. In fact, variability in total 
acceleration was not highly correlated with subjective parameters in the way that the vertical component was. 
However, it is of course not a measure of sleep per se and will include time lying down but not sleeping. The vari-
ability in the sleep cycle could nevertheless be driven either by variability in a hypothetical central clock or in the 
sleep homeostat.
Finally, a substantial number of patients were receiving medication. This appeared to have no average effect 
within or across groups either on variability or the correlations between objective measures and subjective meas-
ures through the statistical tests performed between participants with and without medication. On the face of it, 
a drug like lithium might be expected to reduce variability, but an observational sample is clearly not the optimal 
group in which to demonstrate such an effect.
The traditional measure of heart rate variability (HRV) derived from an ECG, is the most common analysis 
method used in the study of physiology in BD and other psychiatric disorders, with links to emotion39. While 
altered HRV has been reported in BD40,41, alterations to HRV in BPD are not as well defined42,43. Furthermore, 
in previous studies HRV measures were recorded on very controlled five minute sections of ECG, based on tim-
ings between every individual heart beats, where the participants were known to be at rest40,41,44,45. In contrast, 
the results presented in this study are over much longer periods when the participants are behaving as normal, 
therefore recording very different aspects of HR, representative of the spontaneous state and related to diurnal 
changes in HR.
The increased variability in diurnal measures of HR showed striking correlations with mood in BPD and 
much less so in BD and HC. Again, the direction of effect is not established by our observations, but it cannot be 
simply driven by activity or sleep. Instead it may support the idea that BPD really does show greater variability in 
the function of the central diurnal clock. It is the first time that diurnal irregularity has been shown to correlate 
with one of the core features of the BPD phenotype, mood instability. The absence of either greater variability in 
HR measures or a strong relationship with mood suggests that BD is much less likely to be well characterized by 
central instability of clock function, which we did not predict1,46,47.
This was an exploratory study, therefore we had no detailed hypotheses how mood variability might be 
linked to iteams of physiology, although, as previously explained, some link seemed plausible. A relatively 
large number of correlations were calculated between mood and diurnal variability, and strong correlations 
were only found between certain measures of diurnal variability and mood variability (Table 4). Moreover, the 
majority of correlations were found for the BPD group who had more variable mood than either BD or HC. 
Whether this is a result of stronger coupling between physiology and mood will require further work. However, 
the variability of diurnal measures in BPD is less different (from BD and HC) than the mood variability, 
so it may be.
Long term naturalistic monitoring with inconvenient equipment poses real challenges and we collected fewer 
complete and usable sets of data than planned because the available equipment proved less than ideal. Study of 
diurnal rhythms over longer periods could improve the findings reported here, as four days of data is a relatively 
short period and single abnormal days have large effects on fitting the data. The days of the week were not taken 
into account either, so participants may have been recorded over four working days, which might be relatively 
regular, or they may be recorded for two working days and two weekend days, which we would expect to be less 
regular. This added variability may have helped the correlation analysis and will have tended to amplify effects in 
BPD who had the highest emotional variability.
We studied the participants in a relatively stable state as outpatients. It would be interesting, if difficult, to 
study severe mania and depression for the BD group. However, inter-episode states in BD or BPD are ‘at risk’ 
states and the mood/diurnal link is potentially important. Most interesting of all would be the transition from well 
to ill, but this presents a narrow observational window to a relatively rare event and so difficult to capture within 
the time frame of a prospective study.
Diurnal analysis of other measures like temperature, metabolic or inflammatory biomarkers may provide 
further insight into the links between diurnal function and mood, which could be closer to the brain mechanisms 
in BD or BPD.
The ability to detect a correlate of negative or unstable moods from objective measures, such as acceleration or 
HR, improves or complements the current methods of subjective report. With the right equipment, such meas-
ures could be largely frictionless. More continuous monitoring of participants suffering from mental disorders 
may lead to prediction of deteriorating mood states based on changes in diurnal patterns of objective markers, 
therefore allowing for preventative action to be initiated as part of a clinical management plan. Improved methods 
for collecting diurnal information over longer periods of time are required for confirmation and interpretation of 
diurnal signals under a wider range of states of illness.
The present study has established for the first time that variability in diurnal function is associated with 
variability of mood in BPD. It suggests that the associations are present for HR, total activity and the activity 
related to sleep. Any association between subjective experience and objective measures is unlikely to be sim-
ple or unidirectional. However, the results suggest that variable diurnal function is more characteristic of the 
BPD than the BD phenotype and so treatment efforts might be explored which would regularize circadian 
function as a way to regulate abnormal mood in BPD. New ideas are required to move this field forward and 
develop mental health care. Improved regularity of sleep may be an important potential target for therapy 
in both BD and BPD.
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